Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial
Alisertib联合诱导化疗治疗既往未接受治疗的高危急性髓系白血病患者：一项单臂II期试验
期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(19)30203-0
Brunner, Andrew M; Blonquist, Traci M; DeAngelo, Daniel J; McMasters, Malgorzata; Fell, Geoffrey; Hermance, Nicole M; Winer, Eric S; Lindsley, R Coleman; Hobbs, Gabriela S; Amrein, Philip C; Hock, Hanno R; Steensma, David P; Garcia, Jacqueline S; Luskin, Marlise R; Stone, Richard M; Ballen, Karen K; Rosenblatt, Jacalyn; Avigan, David; Nahas, Myrna R; Mendez, Lourdes M; McAfee, Steven L; Moran, Jenna A; Bergeron, Meghan; Foster, Julia; Bertoli, Christina; Manning, Amity L; McGregor, Kristin L; Fishman, Kaitlyn M; Kuo, Frank C; Baltay, Michele T; Macrae, Molly; Burke, Meghan; Behnan, Tanya; Wey, Margaret C; Som, Tina T; Ramos, Aura Y; Rae, Jessica; Lombardi Story, Jennifer; Nelson, Nicole; Logan, Emma; Connolly, Christine; Neuberg, Donna S; Chen, Yi-Bin; Graubert, Timothy A; Fathi, Amir T
